Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain.
Pain Manag
; 14(1): 21-27, 2024 Jan.
Article
em En
| MEDLINE
| ID: mdl-38193288
ABSTRACT
Aim:
Micronutrient and metabolic compound supplementation as a method of treating chronic pain is not well understood. Case A 58 year-old woman presented with refractory painful neuropathy. She did not respond to conservative treatment and was seeking spinal cord stimulator implantation. She underwent a biomarker panel that revealed low intracellular levels of multiple compounds. As she supplemented her deficiencies, her symptoms fully resolved, and the implant was no longer indicated.Discussion:
Micronutrient and metabolic compound testing could potentially expand non-invasive treatment options for patients with refractory chronic pain. Caution should be exercised given limited regulatory oversight in the supplement industry and actively ongoing nutritional research.Conclusion:
Biomarker testing panels may be a useful adjunct in the management of refractory neuropathic pain.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dor Intratável
/
Terapia por Estimulação Elétrica
/
Dor Crônica
/
Neuralgia
Tipo de estudo:
Diagnostic_studies
Idioma:
En
Revista:
Pain Manag
/
Pain manag. (Lond., Online)
/
Pain management (London. Online)
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos